1. Introduction The purpose of this report is to critically assess current purchasing and supply management practices in pharmaceutical industry‚ while looking at such companies as “Pfizer Inc.” and “Eli Lilly and Company”. Globalization‚ technological advances and increased worldwide competition has led to more complex supply chains in the pharmaceutical industry. It is important to acknowledge the increased exposure of these supply chains to risk. ‘The purpose of risk management is to ensure that
Premium Management Supply chain management Risk management
There is a lot of discussion about pharmaceutical companies‚ intellectual property‚ and the global AIDS epidemic. Do pharmaceutical companies have a responsibility to distribute drugs for free or low cost in developing countries? Why is intellectual property such a big deal? What impact would South Africa’s decision to levy duties on drugs in the country have on the international distribution of drugs? Was the change that provided patent protection for pharmaceutical companies an appropriate change
Premium Generic drug Developing country Developed country
Teva Pharmaceutical Industries‚ Ltd 1) External Environment: The Pharmaceutical Industry is dependent on political and legal conditions of general environment. In pharmaceutical industry we have two kind of medications which are generic or innovative. Innovative pharmaceutical industry success depends on the patent protection in the industry. For example‚ in United States innovative industry can have 10 to 12 years of patent protection life from the time that product is for sale in the
Premium Generic drug Pharmaceutical industry Food and Drug Administration
patients” (Abraham 2010:604). According to Abraham (2010)‚ pharmaceuticalization is currently on an upward spiral and this dramatic increase can be attributed to five different factors. These five explanations are biomedicalism‚ medicalization‚ pharmaceutical industry promotion and marketing‚ consumerism‚ and regulatory-state ideology or policy. Each of these explanatory factors are mutually interactive but competing and it will be explained how this is in the following paragraphs. The biomedicalization
Premium Attention-deficit hyperactivity disorder Pharmacology Medicine
Pharmaceutical Marketing Merck “Merck has gone beyond developing and selling prescription pharmaceuticals. It formed joint ventures in 1989 with Johnson & Johnson to sell over the-counter pharmaceuticals; in 1991 with DuPont to expand basic research‚ and in 2000 with Scherigng-Plough to develop and market new prescriptions medicines. In 1997‚ Merck and Rhone-Poulenc S.A. (now Sanofi-Aventis S.A.) combined animal health and poultry genetics business to form Merial Limited‚ a fully integrated
Premium Pharmaceutical industry Pharmacology Clinical trial
OVERVIEW – INDIAN PHARMACEUTICALINDUSTRY | | 1.1 | Current Scenario | 6 | 1.2 | Major Pharmaceutical Companies | 10 | 1.3 | Government Initiatives | 12 | 1.4 | Oncology Segment | 15 | | LUNG CANCER | | 2.1 | World Scenario | 21 | 2.2 | Indian Scenario | 22 | 2.3 | About Lung Cancer | 30 | 2.4 | Stages of Lung Cancer | 36 | 2.5 | Causes of Lung Cancer | 46 | | LONG LIFE PHARMACEUTICALS PVT. LTD. | | 3.1 | Vision and Mission | 48 | 3.2 | Board of Directors | 49 | 3.3
Premium Cancer Lung cancer Oncology
Questions for Review 1. Pharmaceutical companies do have a responsibility to distribute drugs for a low cost in developing and poorer countries. Africa’s GDP‚ and per capita income is very low so they cannot afford to buy top quality medicines. One main argument for this approach is the AIDS epidemic in Africa. A main argument against this is that the treatment for AIDS is very expensive to provide to a whole country for free. 2. The principal arguments of pharmaceutical companies that oppose making
Premium HIV World Trade Organization Pharmacology
Introduction In 1973‚ the UK based multinational pharmaceutical company‚ ICI plc. Established a subsidiary in Dhaka‚ known as ICI Bangladesh Manufacturers Limited. In 1992‚ ICI plc. divested its share to local management‚ and the company was renamed Advanced Chemical Industries (ACI) Limited. ACI formulates and markets a comprehensive range of more than 387 products covering all major therapeutic areas‚ which come in tablet‚ capsule‚ powder‚ liquid‚ cream‚ ointment‚ gel ‚ophthalmic and injection
Premium ISO 9000 Quality management Quality assurance
Beximco Pharmaceutical Ltd is the manufacturer and marketer of pharmaceutical product under chemical divisions of Beximco Group. Beximco Pharmaceuticals is one of the leading pharmaceutical companies in Bangladesh. It also is one of the biggest suppliers of pharmaceutical product of any Bangladeshi based company. BPL is the first Bangladeshi company to supply pharmaceutical product to Riffles Hospital the most prestigious hospital of Singapore. The study has been carried out with the following objectives:
Premium Marketing Pharmaceutical industry Pharmacology
because of the following reasons: (1) Americans unjustly pay up to 5 times more to fill their prescriptions than consumers in other countries; (2) The United States is the largest market for pharmaceuticals in the world‚ yet American consumers pay the highest prices for brand pharmaceuticals in the world; (3) A prescription drug is neither safe nor effective to an individual who cannot afford it; (4) Allowing and structuring the importation of prescription drugs to ensure access to
Free Pharmacology